Faculty profile

Eitan Amir

Back to faculty

ProfessorDepartment of MedicineUniversity of Toronto

Eitan Amir

Professor

Department of Medicine

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

ORCID

Supervision signals

Professors usually supervise graduate students in their department's programs.
81 publications in the last five years, latest in 2026.
Senior (last) author on 21 recent papers, a sign of leading a research group.
Principal investigator on 3 research grants (3 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

323

Publications

718

Citations

h-index

115

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

University Profile Search on Google Scholar iDORCID

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Cardiac Imaging Cardiotoxicity Echocardiography Heart Failure Her-2 Positive Breast Cancer Left Ventricular Ejection Fraction Non-Inferiority Randomized Controlled Trial

Latest papers

International Breast Cancer Trials and Optimal Sequence of Treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026 · senior author
The impact of menopausal status on the efficacy of adjuvant CDK4/6 inhibitors in hormone receptor-positive early breast cancer: a systematic review and meta-analysis of phase III clinical trials.
Breast cancer research and treatment · 2026 · senior author
Cardiovascular Disease in Males With Breast Cancer: A Population-Based Cohort Study.
JACC. Advances · 2026

All 323 publications

Latest funding

Two Brief Interventions for Cancer-related Cognitive Impairment after Breast Cancer: A Randomized Trial
CIHR · 2026 · Co-investigator
$409,276
Feasibility of Two Brief Psychoeducational Interventions for Cancer-Related Cognitive Impairment in Breast Cancer Survivors: A Pilot Randomized Controlled Trial
CIHR · 2025 · Co-investigator
$100,000
The JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year (JUSTIFY) Randomized Controlled Trial
CIHR · 2025 · Principal investigator
$1,487,925

All 14 grants and awards

From the 150 most recent of 323 publications.

International Breast Cancer Trials and Optimal Sequence of Treatment.

Bender U, Ronan K, Amir E

Journal of clinical oncology : official journal of the American Society of Clinical Oncology2026Senior author

DOI: 10.1200/jco-26-01228 PMID: 42696689

The impact of menopausal status on the efficacy of adjuvant CDK4/6 inhibitors in hormone receptor-positive early breast cancer: a systematic review and meta-analysis of phase III clinical trials.

Bender U, Ronan K, Aljuhani A, Savill J, Amir E

Breast cancer research and treatment2026Senior author

DOI: 10.1007/s10549-026-08056-7 PMID: 42593586

Cardiovascular Disease in Males With Breast Cancer: A Population-Based Cohort Study.

Chauhan A, Giannakeas V, Thiruchelvam D, Thavendiranathan P, Amir E, Nadler MB, Savard MF, Abdel-Qadir H

JACC. Advances2026

DOI: 10.1016/j.jacadv.2026.102937 PMID: 42489382

Differential Treatment Effects by Smoking Status for NSCLC Therapies (2010-2023): A Meta-Analysis.

Favorito FM, Ynoe de Moraes F, Valiente CM, Nadler MB, Desnoyers A, Amir E, Wilson BE

JTO clinical and research reports2026

DOI: 10.1016/j.jtocrr.2025.100843 PMID: 42305404

The role of stereotactic body radiotherapy in oligoprogressive breast cancer: A site-specific analysis of the prospective, phase-II RADIANT trial.

Ruicci KM, Helou J, Barry A, Ye XY, Koch CA, Croke J, Han K, Rodin D, Hahn E, Kwan JYY, Yan M, Liu FF, Lindsay P, Javor J, Bedard P, Cescon D, Kumar V, Amir E, Nadler MB, Lee R, Glicksman RM

Clinical and translational radiation oncology2026

DOI: 10.1016/j.ctro.2026.101164 PMID: 42011409

Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapy.

Elliott MJ, Fuentes-Antrás J, Main SC, Dou A, Shah E, Weipert C, Yalamanchili G, Bird T, Roh J, Yu C, Nadler MB, Amir E, Berman HK, Siu LL, Bedard PL, Cescon DW

Nature communications2026

DOI: 10.1038/s41467-026-73126-9 PMID: 42243127

Longitudinal evaluation of serial ctDNA kinetics using joint modeling in patients with metastatic breast cancer.

Pretz C, Fuentes-Antrás J, Main S, Dou A, Shah E, Van de Laar E, Weipert CM, Lin B, Das A, Amir E, Nadler MB, Yu C, Berman HK, Siu LL, Bedard PL, Elliott MJ, Cescon DW

NPJ precision oncology2026

DOI: 10.1038/s41698-026-01498-8 PMID: 42236890

Navigating Treatment Decisions in Early-Stage Hormone Receptor-Positive Breast Cancer.

Amir E, Kristoff T, Blaha C, Bender U, Kalinsky K, Cobain E

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting2026First author

DOI: 10.1200/edbk-26-520488 PMID: 42208010

ASO Visual Abstract: Breast Cancer Surgery Wait Times and COVID-19-A Canadian Population-Based Analysis.

Ko G, Li Q, Liu N, Amir E, Covelli AM, Eskander A, Freitas V, Koch CA, Ramruthan J, Reel E, Roberts A, Zhong T, Cil TD

Annals of surgical oncology2026

DOI: 10.1245/s10434-026-19185-0 PMID: 41772249

Breast Cancer Surgery Wait Times and COVID-19: A Canadian Population-Based Analysis.

Ko G, Li Q, Liu N, Amir E, Covelli AM, Eskander A, Freitas V, Koch CA, Ramruthan J, Reel E, Roberts A, Zhong T, Cil TD

Annals of surgical oncology2026

DOI: 10.1245/s10434-025-19029-3 PMID: 41580537

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Eitan Amir

Research

Latest papers

Latest funding

International Breast Cancer Trials and Optimal Sequence of Treatment.

The impact of menopausal status on the efficacy of adjuvant CDK4/6 inhibitors in hormone receptor-positive early breast cancer: a systematic review and meta-analysis of phase III clinical trials.

Cardiovascular Disease in Males With Breast Cancer: A Population-Based Cohort Study.

Differential Treatment Effects by Smoking Status for NSCLC Therapies (2010-2023): A Meta-Analysis.

The role of stereotactic body radiotherapy in oligoprogressive breast cancer: A site-specific analysis of the prospective, phase-II RADIANT trial.

Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapy.

Longitudinal evaluation of serial ctDNA kinetics using joint modeling in patients with metastatic breast cancer.

Navigating Treatment Decisions in Early-Stage Hormone Receptor-Positive Breast Cancer.

ASO Visual Abstract: Breast Cancer Surgery Wait Times and COVID-19-A Canadian Population-Based Analysis.

Breast Cancer Surgery Wait Times and COVID-19: A Canadian Population-Based Analysis.

Frequent collaborators

Paaladinesh Thavendiranathan

Mark Clemons

Toni Zhong

Ning Liu

Chris McIntosh

Paul Yip

Philippe Bedard

Ron Wald

Gregory Pond

Kate Hanneman

Monika Krzyzanowska

Urban Emmenegger

Manon Lemonde

Josee-Lyne Ethier

Ewa Szumacher

Brian Hutton

Doris Howell

Antoine Eskander

George Tomlinson

Simon Bergman

Filio Billia

Christina Addison

Danielle Rodin

Fei-Fei Liu

Amirrtha Srikanthan

Vasily Giannakeas

John Hilton

Melanie Powis

Kristen Haase

Martine Puts

Steven Gallinger

Lisa Wang

Marie-France Savard

Gregory Pond

Michael Yan

Meredith Giuliani

Paul Wheatley-Price

Ellen Greenblatt

Fernando Rivera-Theurel

Lisa Avery